相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
Xia Zhang et al.
Frontiers in Oncology (2023)
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
Kyunghye Bang et al.
CANCER MEDICINE (2023)
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Amit G. Singal et al.
HEPATOLOGY (2023)
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
Wei-Feng Qu et al.
HEPATOLOGY INTERNATIONAL (2023)
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Benjamin V. Tran et al.
LIVER TRANSPLANTATION (2023)
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation
Joshua S. Norman et al.
JOURNAL OF HEPATOLOGY (2023)
The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
Letizia Todeschini et al.
CURRENT ONCOLOGY (2023)
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road
Yufeng Gu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2023)
Laparoscopic Left Hepatectomy for Hepatocellular Carcinoma Recurrence Following Liver Transplantation
Marco Colasanti et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry
Giovanni Battista Levi Sandri et al.
UPDATES IN SURGERY (2022)
Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence
Khalid Bzeizi et al.
CANCERS (2022)
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation
Simone Lasagni et al.
FRONTIERS IN ONCOLOGY (2022)
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
Charlotte Costentin et al.
JHEP REPORTS (2022)
Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis
Vladimir J. Lozanovski et al.
BJS OPEN (2022)
Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
Marco Biolato et al.
CANCERS (2021)
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
Massimo Iavarone et al.
LIVER TRANSPLANTATION (2021)
Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Yong Ho Jeong et al.
ANNALS OF TRANSPLANTATION (2021)
Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation
Federica Invernizzi et al.
TRANSPLANTATION (2020)
Liver transplantation for hepatocellular carcinoma: Management after the transplant
Elizabeth C. Verna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Advances in resection and transplantation for hepatocellular carcinoma
Eric Vibert et al.
JOURNAL OF HEPATOLOGY (2020)
En Bloc lumpectomy of T12 vertebra for progressive hepatocellular carcinoma metastases following liver transplantation A case report
Jin-Gen Hu et al.
MEDICINE (2020)
Feasibility and efficacy of repeat laparoscopic liver resection for recurrent hepatocellular carcinoma
Takashi Onoe et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)
Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study
Michela Assalino et al.
TRANSPLANT INTERNATIONAL (2020)
Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival
David D. Lee et al.
TRANSPLANTATION (2020)
Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Sunyoung Lee et al.
LIVER INTERNATIONAL (2020)
Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter Experience
Federica Invenizzi et al.
FRONTIERS IN ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis
Itunu Owoyemi et al.
CANCER (2020)
Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience
Zhe Yang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2020)
Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
Xiaoxiao Du et al.
FRONTIERS IN IMMUNOLOGY (2020)
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2020)
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Marina Berenguer et al.
TRANSPLANTATION (2020)
Perioperative outcomes comparing laparoscopic with open repeat liver resection for post-hepatectomy recurrent liver cancer: A systematic review and meta-analysis
Yuelong Liang et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Systematic review with meta-analysis: sirolimus-or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
Sam E. Grigg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
Massimo Iavarone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Outcomes of laparoscopic repeat liver resection for recurrent liver cancer A system review and meta-analysis
Yufu Peng et al.
MEDICINE (2019)
Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects
Hong Lei et al.
FRONTIERS IN IMMUNOLOGY (2019)
Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation
Nicolas Goldaracena et al.
HPB (2019)
Adrenalectomy for solitary recurrent hepatocellular carcinoma five years after living donor liver transplantation: A case report
Mohamed Abdel Wahab et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2019)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma
Xiaofeng Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Specific issues concerning the management of patients on the waiting list and after liver transplantation
Patrizia Burra et al.
LIVER INTERNATIONAL (2018)
Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry
Hans-Christian Pommergaard et al.
HPB (2018)
The surgical challenges of salvage living donor liver transplantation for Hepatocellular carcinoma; The cumulative experience of 100 cases - A retrospective cohort study and a propensity score analysis
Chee-Chien Yong et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Is it Time to Abandon the Milan Criteria? Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies
Karim J. Halazun et al.
ANNALS OF SURGERY (2018)
Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database
Neil Mehta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient
P. Biondani et al.
ANNALS OF ONCOLOGY (2018)
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience
Thomas T. DeLeon et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient
Enrico N. De Toni et al.
GASTROENTEROLOGY (2017)
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
Andrea Notarpaolo et al.
JOURNAL OF HEPATOLOGY (2017)
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models
Charlotte E. Costentin et al.
LIVER INTERNATIONAL (2017)
Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
Elena Fernandez-Sevilla et al.
LIVER TRANSPLANTATION (2017)
Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma
Brian D. Friend et al.
PEDIATRIC BLOOD & CANCER (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
Neil Mehta et al.
JAMA ONCOLOGY (2017)
Acute liver graft rejection after ipilimumab therapy
S. Dueland et al.
ANNALS OF ONCOLOGY (2017)
Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation Impact of Treatment Modality and Recurrence Characteristics
Adam S. Bodzin et al.
ANNALS OF SURGERY (2017)
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Charles Herbaux et al.
BLOOD (2017)
Why do patients die after a liver transplantation?
Kim E. Daniel et al.
CLINICAL TRANSPLANTATION (2017)
Surgical Resection for Lymph Node Metastasis After Liver Transplantation for Hepatocellular Carcinoma
Toru Ikegami et al.
ANTICANCER RESEARCH (2017)
Recurrence After Liver Transplantation for Hepatocellular Carcinoma A New MORAL to the Story
Karim J. Halazun et al.
ANNALS OF SURGERY (2017)
A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score
Quirino Lai et al.
ANNALS OF SURGERY (2016)
The Extended Toronto Criteria for Liver Transplantation in Patients With Hepatocellular Carcinoma: A Prospective Validation Study
Gonzalo Sapisochin et al.
HEPATOLOGY (2016)
CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
Chang Xian Li et al.
JOURNAL OF HEPATOLOGY (2016)
Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?
Jiwei Huang et al.
JOURNAL OF SURGICAL RESEARCH (2016)
An early look at the Organ Procurement and Transplantation Network explant pathology form data
Ann M. Harper et al.
LIVER TRANSPLANTATION (2016)
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K. Geissler et al.
TRANSPLANTATION (2016)
Adrenalectomy for solitary metastasis of Hepatocellular carcinoma post liver transplantation: Case report and literature review
Imran Khan Jalbani et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2016)
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
Christian Toso et al.
HEPATOLOGY (2015)
Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: An analysis of 11 cases (Publication with Expression of Concern. See vol. 37, pg. 338, 2020)
Hongyan Zhai et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2015)
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
Nicola de'Angelis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
G. Sapisochin et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The prognosis and treatment outcomes of patients with recurrent hepatocellular carcinoma after liver transplantation
Young-Nam Roh et al.
CLINICAL TRANSPLANTATION (2014)
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report
Enrico Gringeri et al.
PROGRESS IN TRANSPLANTATION (2014)
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review
Evangelos Cholongitas et al.
TRANSPLANT INTERNATIONAL (2014)
Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
K. V. Menon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
Carlo Sposito et al.
JOURNAL OF HEPATOLOGY (2013)
Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma
Manuel Rodriguez-Peralvarez et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Michael R. Lucey et al.
LIVER TRANSPLANTATION (2013)
New OPTN/UNOS Policy for Liver Transplant Allocation: Standardization of Liver Imaging, Diagnosis, Classification, and Reporting of Hepatocellular Carcinoma
Christoph Wald et al.
RADIOLOGY (2013)
Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma
A. R. Hakeem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation
Quirino Lai et al.
CLINICAL TRANSPLANTATION (2012)
Incidence and Risk Factors of Hepatocellular Carcinoma Recurrence After Liver Transplantation in the MELD Era
Pratima Sharma et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
Wenhua Liang et al.
LIVER TRANSPLANTATION (2012)
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
Carlos Gomez-Martin et al.
LIVER TRANSPLANTATION (2012)
Resection of Pulmonary Metastases from Hepatocellular Carcinoma following Liver Transplantation
Shin Hwang et al.
WORLD JOURNAL OF SURGERY (2012)
Radiofrequency Ablation Versus Surgical Resection for Hepatocellular Carcinoma in Childs A Cirrhotics-a Retrospective Study of 1,061 Cases
Jiwei Huang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma: An Evidence-Based Analysis of 15 Years of Experience
Vincenzo Mazzaferro et al.
LIVER TRANSPLANTATION (2011)
Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: Clinical patterns and outcome variables
A. Kornberg et al.
EJSO (2010)
Sirolimus-Based Immunosuppression Is Associated with Increased Survival After Liver Transplantation for Hepatocellular Carcinoma
Christian Toso et al.
HEPATOLOGY (2010)
Chemoembolization with Lobaplatin Mixed with Iodized Oil for Unresectable Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
Bin Zhou et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Role of surgical resection for pulmonary metastasis of hepatocellular carcinoma
Kook Nam Han et al.
LUNG CANCER (2010)
Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
A. Valdivieso et al.
TRANSPLANTATION PROCEEDINGS (2010)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation
Michael J. Bates et al.
ANNALS OF THORACIC SURGERY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
Francis Y. Yao et al.
HEPATOLOGY (2008)
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
Michael A. Zimmerman et al.
LIVER TRANSPLANTATION (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Recurrence of hepatocellular carcinoma after liver transplantation
A. Escartin et al.
TRANSPLANTATION PROCEEDINGS (2007)
Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation
Heung-Kyu Ko et al.
KOREAN JOURNAL OF RADIOLOGY (2007)
A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma
Sung Hoon Yang et al.
SURGERY (2007)
Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants
Shimul A. Shah et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database
Richard B. Freeman et al.
LIVER TRANSPLANTATION (2006)
Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma
Shimul A. Shah et al.
TRANSPLANTATION (2006)
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
MS Chen et al.
ANNALS OF SURGERY (2006)
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression
M Vivarelli et al.
LIVER TRANSPLANTATION (2005)
Liver transplantation for hepatocellular carcinoma in cirrhosis:: Is clinical tumor classification before transplantation realistic?
GC Sotiropoulos et al.
TRANSPLANTATION (2005)
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma
U Cillo et al.
ANNALS OF SURGERY (2004)
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
NM Kneteman et al.
LIVER TRANSPLANTATION (2004)
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver
M Vivarelli et al.
ANNALS OF SURGERY (2004)
Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression
M Maluccio et al.
TRANSPLANTATION (2003)
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma
M Minagawa et al.
ANNALS OF SURGERY (2003)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
S Jonas et al.
HEPATOLOGY (2001)
分享论文
